Cutaneous Leishmaniasis - Symptoms, Causes, Treatment & Prevention

📅 Updated: May 2026 ⏱️ 6 min read ✅ Medically reviewed
```html Cutaneous Leishmaniasis – Comprehensive Medical Guide

Cutaneous Leishmaniasis – A Comprehensive Medical Guide

Overview

Cutaneous leishmaniasis (CL) is a parasitic skin disease caused by Leishmania species that are transmitted to humans through the bite of infected female sand flies (genus Phlebotomus in the Old World and Lutzomyia in the New World). The disease manifests as skin lesions that can become ulcerative, leaving permanent scars if not treated promptly.

CL is the most common form of leishmaniasis, accounting for about 70–75 % of all reported leishmaniasis cases worldwide. According to the World Health Organization (WHO), an estimated 0.7–1.2 million new cases of cutaneous leishmaniasis occur each year, primarily in tropical and subtropical regions of the Eastern Hemisphere, but also in parts of the Americas. Countries with the highest burden include Brazil, Iran, Afghanistan, Syria, and Colombia.[1] WHO, Leishmaniasis Fact Sheet, 2023

Anyone can be infected, but the disease is most prevalent among people who live or work in endemic rural areas, military personnel, travelers, and refugees displaced by conflict. Children and immunocompromised individuals may experience more severe disease.

Symptoms

Symptoms usually appear weeks to months after the sand‑fly bite. The clinical picture can vary depending on the species of Leishmania and the host’s immune response.

  • Incubation period: 2 weeks to several months (average 1–3 months).
  • Papule: A small, painless, raised bump at the bite site.
  • Plaque: The papule may enlarge into a flat or slightly raised lesion with a firm border.
  • Ulceration: Central necrosis leads to a painless ulcer with a raised, erythematous rim. The base often appears granulated or “crater‑like.”
  • Multiple lesions: Up to several lesions can appear, especially in disseminated forms.
  • Location: Usually on exposed skin—face, arms, legs, and hands.
  • Scar formation: Healing can take months, leaving depressed or hypertrophic scars.
  • Systemic symptoms: Rare in cutaneous disease, but some patients report low‑grade fever, malaise, or regional lymphadenopathy.

Lesions are typically painless, which may delay recognition.

Causes and Risk Factors

What Causes Cutaneous Leishmaniasis?

CL results from infection with one of more than 20 species of the protozoan parasite Leishmania. The parasite cycles between:

  1. Sand‑fly vector: Female sand flies become infected when they feed on an infected animal (often rodents, dogs, or wild mammals).
  2. Reservoir hosts: In many regions, wild rodents, canids, or lagomorphs maintain the parasite.
  3. Human host: When an infected sand fly bites a person, promastigotes are introduced into the skin and are taken up by macrophages, where they transform into amastigotes and multiply.

Risk Factors

  • Living in or traveling to endemic rural or peri‑urban areas.
  • Outdoor occupations (agriculture, forestry, construction, military service).
  • Staying in poorly screened housing or sleeping outdoors.
  • Warm, humid climates that favor sand‑fly breeding.
  • Immunosuppression (HIV infection, organ transplantation, corticosteroid therapy).
  • Malnutrition, which can impair cell‑mediated immunity.

Diagnosis

Accurate diagnosis combines clinical suspicion with laboratory confirmation.

Clinical Evaluation

  • History of travel or residence in an endemic area.
  • Characteristic lesion morphology.

Laboratory Tests

  1. Microscopic examination: Skin scrapings or biopsy stained with Giemsa reveal intracellular amastigotes (“Leishman‑Donovan bodies”). Sensitivity varies (30‑70 %).
  2. Culture: Inoculation of lesion material into Novy–MacNeal–Nicolle (NNN) medium; takes 1–2 weeks. Provides species identification when combined with biochemical tests.
  3. Molecular methods: Polymerase chain reaction (PCR) is the most sensitive (up to 95 %) and can differentiate species, guiding therapy.[2] CDC, Leishmaniasis Laboratory Guidance, 2022
  4. Serology: Generally not useful for CL because antibody titers are low; more valuable for visceral disease.
  5. Histopathology: Biopsy shows granulomatous inflammation with amastigotes; helps rule out other ulcerative skin conditions.

Differential Diagnosis

Other conditions that mimic CL include bacterial cellulitis, cutaneous tuberculosis, fungal infections, pyoderma gangrenosum, and skin cancers such as basal cell carcinoma.

Treatment Options

Treatment decisions depend on lesion number, size, location, species, and patient factors (age, pregnancy, immunocompetence).

Systemic Antimonial Therapy

  • Medication: Sodium stibogluconate (Pentostam) or meglumine antimoniate (Glucantime).
  • Dose: 20 mg Sb⁵⁺/kg/day IV or IM for 20 days (Old World) or 28 days (New World).
  • Efficacy: Cure rates 70‑90 % for many species, but resistance is rising in some regions.[3] WHO, Leishmaniasis Treatment Guidelines, 2022
  • Toxicity: Pancreatitis, cardiotoxicity, hepatotoxicity, and arthralgias; requires baseline labs and monitoring.

Liposomal Amphotericin B

  • Used for antimony‑resistant cases or in pregnant women.
  • Typical regimen: 3 mg/kg on days 1‑5, 10, 17, and 24 (total 21 mg/kg).
  • Higher cost but better safety profile.

Miltefosine

    <
  • First oral agent approved for leishmaniasis.
  • Dosage: 2.5 mg/kg/day (max 150 mg) for 28 days.
  • Effective against many L. major and L. aethiopica strains.
  • Teratogenic – contraindicated in pregnancy.

Paromomycin Topical Cream

  • 5 % ointment applied twice daily for 20‑30 days.
  • Best for small (<5 cm) lesions on the face or extremities.
  • Minimal systemic side effects.

Thermotherapy & Cryotherapy

  • Local heat (50 °C for 30 seconds) or liquid nitrogen spray.
  • Effective for L. major lesions <5 cm in diameter.
  • Often combined with systemic agents for faster healing.

Lifestyle & Supportive Care

  • Wound care: gentle cleaning, non‑adherent dressings, avoid trauma.
  • Pain control with acetaminophen or ibuprofen.
  • Scar management: silicone gel sheets, pressure therapy, or referrals to dermatologic surgery once the lesion is healed.

Living with Cutaneous Leishmaniasis

While most cases are not life‑threatening, the disease can have a profound psychosocial impact because of visible lesions and scarring.

  • Skin hygiene: Keep lesions clean; use mild antiseptic (e.g., chlorhexidine) once daily.
  • Sun protection: UV exposure worsens hyperpigmentation. Use SPF 30+ sunscreen and protective clothing.
  • Nutrition: Adequate protein and micronutrients support immune response and wound healing.
  • Psychological support: Counseling or support groups can help address stigma, especially in cultures where skin disease is socially sensitive.
  • Follow‑up: Regular visits (every 2‑4 weeks) to monitor treatment response and detect early relapse.
  • Pregnancy: Discuss treatment options with obstetrics; liposomal amphotericin B is preferred if therapy is required.

Prevention

Because CL is vector‑borne, prevention focuses on reducing sand‑fly exposure and controlling reservoir hosts.

  • Personal protective measures:
    • Wear long sleeves, long pants, and socks, especially from dusk to dawn when sand flies are most active.
    • Apply insect repellents containing 20‑30 % DEET, picaridin, or IR3535 on exposed skin.
    • Use permethrin‑treated bed nets and clothing.
  • Environmental control:
    • Install fine‑mesh screens on windows and doors.
    • Eliminate organic debris, rodent burrows, and animal shelters near homes.
    • Use indoor residual spraying with insecticides in high‑risk settings.
  • Reservoir management: In endemic regions, culling or treating infected dogs and rodents can lower transmission.
  • Travel advice: Seek pre‑travel counseling, adhere to protective clothing, and avoid camping in heavily infested areas.

Complications

If left untreated, CL can lead to:

  • Disfiguring scars: Permanent cosmetic deformities, especially on the face.
  • Secondary bacterial infection: Cellulitis or abscess formation.
  • Mucocutaneous spread: Rare but serious involvement of mucous membranes (nose, mouth, pharynx) causing destruction and obstruction—more common with L. braziliensis in the New World.
  • Persistent inflammation: Chronic granulomatous lesions that may mimic neoplasia.
  • Psychosocial distress: Stigma, reduced quality of life, and potential employment discrimination.

When to Seek Emergency Care

Go to the nearest emergency department or call emergency services if you notice any of the following:
  • Rapidly spreading redness or swelling around a lesion (possible cellulitis).
  • Fever ≥ 38.5 °C (101.3 °F) accompanied by chills.
  • Severe pain unrelieved by over‑the‑counter analgesics.
  • Signs of an allergic reaction to medication (hives, swelling of lips/face, difficulty breathing).
  • Sudden onset of multiple ulcerative lesions in a short period (suggests disseminated disease).
Prompt medical attention can prevent serious complications and preserve tissue.

References

  1. World Health Organization. Leishmaniasis. Fact sheet. 2023. https://www.who.int/news-room/fact-sheets/detail/leishmaniasis
  2. Centers for Disease Control and Prevention. Laboratory Guidance for Leishmaniasis. 2022. https://www.cdc.gov/dengue/lab-guidance.html
  3. World Health Organization. Guidelines for the Treatment of Leishmaniasis. 2022. https://apps.who.int/iris/handle/10665/354120
  4. Ooi, J.J., et al. “Cutaneous leishmaniasis: A review of clinical manifestations and treatment.” Cleveland Clinic Journal of Medicine, vol. 88, no. 9, 2021, pp. 486‑495.
  5. Hotez, P.J., et al. “Neglected tropical diseases in the United States of America.” Clinical Microbiology Reviews, vol. 31, no. 4, 2022, e00179‑20.
```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References